NCT00433875View on ClinicalTrials.gov

Phase 2 AMG 714 in Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 31, 2002

Conditions
Rheumatoid Arthritis
Interventions
DRUG

AMG 714

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00433875 - Phase 2 AMG 714 in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter